CARM Carisma Tx Total Asset Value of Company
This chart of the current share price reflects the aggregate asset dynamics of Carisma Therapeutics (CARM), which is capturing the niche of combating solid tumors by expanding its reach in precision medicine. The company's capitalization is based on the development of CAR-M technologies and a strategic alliance with Moderna. A flawless reputation as a scientific pioneer and the support of global corporations secure the company's status as a trusted partner, and the metric stands at 32.18.
Analytical breakdowns and data insights for company carismatx.com (CARM)
- price and consensus price forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Carisma Therapeutics|CARM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Carisma Therapeutics Inc.|CARM - Company Aggregate Debts|Debts to Book Capitalization CARM|CARM - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Carisma Therapeutics|Interim Coverage Ratio carismatx.com
- net income and valuation multiples indicators:
Fundamental valuation:Carisma Therapeutics
Total assets represent the aggregate value of all company resources, calculated inversely via return on assets (ROA) to determine the actual capital base. By analyzing the current level of total assets, an investor assesses the financial stability of Carisma Therapeutics (CARM) in developing breakthrough macrophage therapy, where the capitalization of intellectual property determines the business's ability to eliminate solid tumors.
Key competitors
Cumulative Company Assets argenx.com|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|Rigel Corp (RIGL) - Cumulative Company Assets|ANAB: Company Total Assets|astriatx.com (ATXS) - Company Total Assets|Aggregate Company Assets enGene|RAPT: Aggregate Asset Value|Company Total Assets JBIO|Company Total Asset Base Aclaris Therapeutics, Inc|Aggregate Company Assets Kyverna Therapeutics KYTX|Company Total Asset Base tizianalifesciences.com (TLSA)|CABA - Aggregate Company Assets|Ventyx Biosciences Inc. (VTYX) - Cumulative Company Assets|THTX: Company Total Assets|Avalo Therapeutics Inc (AVTX) - Company Total Assets|Cumulative Company Assets ELDN|AGEN: Aggregate Asset Value|Cumulative Company Assets CLYM (Climb Bio)|Aggregate Business Assets ZURA|Company Total Assets ATYR (aTyr)|Aggregate Asset Value ADAG|Ikena Oncology, Inc. - Company Total Assets|Company Assets Shattuck Labs, Inc.|equilliumbio.com (EQ) - Aggregate Company Assets|Connect Biopharma Holdings Limited - Aggregate Asset Value|IMUX (Immunic Therapeutics) - Company Total Assets|Company Total Assets Atara Biotherapeutics Inc|Aggregate Company Assets InflaRx N.V. (IFRX)|XFOR: Total Asset Value of Company|Company Total Assets ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Company Assets|INMB: Cumulative Company Assets|BRNS - Company Total Assets|KZR (Kezar Life Sciences) - Cumulative Company Assets|SABS: Aggregate Business Assets|AKTX (Akari Therapeutics Plc) - Company Total Assets|Enlivex Therapeutics, Ltd. (ENLV) - Company Total Asset Base|Company Total Assets QTTB|Cumulative Company Assets GeoVax Corp GOVX|Aggregate Company Assets Edesa Biotech, Inc. EDSA|Company Total Asset Base ibioinc.com (IBIO)|XTL Biopharmaceuticals Ltd. - Company Total Assets|Bolt Biotherapeutics (BOLT) - Cumulative Company Assets|HCWB: Company Total Assets|Aptevo Therapeutics Inc. (APVO) - Company Total Assets|Aggregate Company Assets AIM ImmunoTech Inc.|ADTX: Aggregate Asset Value|Aggregate Company Assets GRI Bio (GRI)|Cumulative Company Assets XORTX Therapeutics Inc XRTX|Aggregate Company Assets ReShape Lifesciences HIND|REVB (Revelation Biosciences Corp) - Total Asset Value of Company|Indaptus Therapeutics - Company Total Assets|Aggregate Asset Value SCNI (scinai.com)|CALI: Company Total Assets|Affimed N.V. (AFMD) - Company Total Assets|Aggregate Company Assets Allakos Inc|HOOK: Aggregate Asset Value|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|Cumulative Company Assets iteostherapeutics.com ITOS|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD: Cumulative Company Assets